Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:32 PM UTC
| NCT Number | NCT07581002 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 660 participants |
| Active Locations | 3 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 28, 2026 (3 days ago) |
As of August 31, 2026: Clinical trial NCT07581002 is currently recruiting participants. This phase2 study for acute myeloid leukemia is actively seeking new participants at 3 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07581002 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07581002 was last updated 3 days ago (August 28, 2026). HelloStudys verifies this status automatically.